Clinical Trials Browser

Terminated × Penile Neoplasms × pembrolizumab × Clear all

NCT02837042 2022-06-21

Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma

Phase 2 Terminated

6 enrolled 10 charts

Penile Neoplasms, Neoplasms, Squamous Cell